Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 363845, 9 pages
http://dx.doi.org/10.1155/2012/363845
Research Article

Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients

1First Affiliated Hospital, Shanxi University of Medical, Taiyuan 030001, China
2Endocrine Key Laboratory of the Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1 Shuaifuyuan, Wangfujing, Beijing 100730, China

Received 9 October 2011; Revised 29 December 2011; Accepted 29 December 2011

Academic Editor: Hao Xu

Copyright © 2012 Jing Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Micol Tillhon, Luis M. Guamán Ortiz, Paolo Lombardi, and A. Ivana Scovassi, “Berberine: New perspectives for old remedies,” Biochemical Pharmacology, vol. 84, no. 10, pp. 1260–1267, 2012. View at Publisher · View at Google Scholar
  • Francesco Orio, Giovanna Muscogiuri, Stefano Palomba, Silvia Savastano, Alessio Volpe, Marcello Orio, Giorgio Colarieti, Giovanni Battista La Sala, Annamaria Colao, Francesca Marciano, Antonio Ascione, and Pietro Putignano, “Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity,” e-SPEN Journal, 2013. View at Publisher · View at Google Scholar
  • Karina G. Pérez-Rubio, Manuel González-Ortiz, Esperanza Martínez-Abundis, José A. Robles-Cervantes, and María C. Espinel-Bermúdez, “Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion,” Metabolic Syndrome and Related Disorders, pp. 130628073358006, 2013. View at Publisher · View at Google Scholar
  • Yang Liu, Li Zhang, Haiyan Song, and Guang Ji, “Update on Berberine in Nonalcoholic Fatty Liver Disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Sandip K. Dash, “Cognitive impairment and diabetes,” Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, vol. 7, no. 2, pp. 155–165, 2013. View at Publisher · View at Google Scholar
  • Sandra Maria Barbalho, Patrícia Cincotto dos Santos Bueno, Débora Souza Delazari, Elen Landgraf Guiguer, Daniel Pereira Coqueiro, Adriano Cressoni Araújo, Maricelma da Silva Soares de Souza, Flávia M.V. Farinazzi-Machado, Claudemir Gregório Mendes, and Milton Groppo, “ Antidiabetic and Antilipidemic Effects of Manilkara zapota ,” Journal of Medicinal Food, pp. 140903121021000, 2014. View at Publisher · View at Google Scholar
  • Massimiliano Ruscica, Monica Gomaraschi, Giuliana Mombelli, Chiara Macchi, Raffaella Bosisio, Franco Pazzucconi, Chiara Pavane, Laura Calabresi, Anna Arnoldi, Cesare R. Sirtori, and Paolo Magni, “Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus,” Journal of Clinical Lipidology, vol. 8, no. 1, pp. 61–68, 2014. View at Publisher · View at Google Scholar
  • Zheng Li, Ya-Na Geng, Jian-Dong Jiang, and Wei-Jia Kong, “Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Angela Pirillo, and Alberico Luigi Catapano, “Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies,” Atherosclerosis, 2015. View at Publisher · View at Google Scholar
  • Claudia Fabiola Alcala-Hernandez, Laura Alejandra de la Rosa, Abraham Wall-Medrano, Jose Alberto Lopez-Diaz, and Emilio Alvarez-Parrilla, “Advances In Pharmacological And Phytochemical Adipogenesis Therapy,” Nutricion Hospitalaria, vol. 32, no. 2, pp. 545–555, 2015. View at Publisher · View at Google Scholar
  • Young Song, Yonghee Lee, Hyeong Kim, Moo Hyun, Yun Lim, Kye Song, and Beom Kim, “Berberine regulates melanin synthesis by activating PI3K/AKT, ERK and GSK3β in B16F10 melanoma cells,” International Journal of Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Bing Pang, Lin-Hua Zhao, Qiang Zhou, Tian-Yu Zhao, Han Wang, Cheng-Juan Gu, and Xiao-Lin Tong, “Application of Berberine on Treating Type 2 Diabetes Mellitus,” International Journal of Endocrinology, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Schohraya Spahis, Edgard Delvin, Jean-Michel Borys, and Emile Levy, “Oxidative Stress As A Critical Factor In Nonalcoholic Fatty Liver Disease Pathogenesis,” Antioxidants & Redox Signaling, 2016. View at Publisher · View at Google Scholar
  • Fen Li, Yun-bin Zhao, Ding-kun Wang, Xin Zou, Ke Fang, and Kai-fu Wang, “Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells,” Journal of Huazhong University of Science and Technology [Medical Sciences], vol. 36, no. 1, pp. 64–69, 2016. View at Publisher · View at Google Scholar
  • Xin Gao, Xiaopeng Zhu, and Hua Bian, “The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease,” Molecules, vol. 21, no. 10, 2016. View at Publisher · View at Google Scholar
  • Yogita Rochlani, Naga Venkata Pothineni, Swathi Kovelamudi, and Jawahar L. Mehta, “Metabolic syndrome: pathophysiology, management, and modulation by natural compounds,” Therapeutic Advances in Cardiovascular Disease, pp. 175394471771137, 2017. View at Publisher · View at Google Scholar
  • Yanwen Wang, and Jeffrey A. Zidichouski, “Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis,” Cholesterol, vol. 2018, pp. 1–17, 2018. View at Publisher · View at Google Scholar
  • Xueling Ma, Zhongjun Chen, Le Wang, Gesheng Wang, Zihui Wang, XiaoBo Dong, Binyu Wen, and Zhichen Zhang, “The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Chao Niu, Li Yin, and Haji Aisa, “Novel Furocoumarin Derivatives Stimulate Melanogenesis in B16 Melanoma Cells by Up-Regulation of MITF and TYR Family via Akt/GSK3β/β-Catenin Signaling Pathways,” International Journal of Molecular Sciences, vol. 19, no. 3, pp. 746, 2018. View at Publisher · View at Google Scholar
  • Songyan Meng, Fan Yang, Yueqiu Wang, Ying Qin, Huimin Xian, Hui Che, and Lihong Wang, “Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling,” Cell Biology International, vol. 43, no. 1, pp. 65–72, 2018. View at Publisher · View at Google Scholar
  • Mohsen Imenshahidi, and Hossein Hosseinzadeh, “ Berberine and barberry ( Berberis vulgaris ): A clinical review ,” Phytotherapy Research, 2019. View at Publisher · View at Google Scholar